Prophylatic cranial irradiation (PCI) in patients (Pts) with stage IV metastatic melanoma (MM) receiving concurrent biochemotherapy (cBCT) and maintenance biotherapy (MBT) No significant financial ...
Heparanase and Survivin—potential markers of aggressiveness of colon cancers No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2007 ASCO Annual Meeting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback